| For: | Han QJ, Mu YL, Zhao HJ, Zhao RR, Guo QJ, Su YH, Zhang J. Fasudil prevents liver fibrosis via activating natural killer cells and suppressing hepatic stellate cells. World J Gastroenterol 2021; 27(24): 3581-3594 [PMID: 34239271 DOI: 10.3748/wjg.v27.i24.3581] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v27/i24/3581.htm |
| Number | Citing Articles |
| 1 |
Pingping Liu, Zhenghui Xiao, Xiulan Lu, Xinping Zhang, Jiaotian Huang, Cheng Li. Fasudil and SR1001 synergistically protect against sepsis-associated pancreatic injury by inhibiting RhoA/ROCK pathway and Th17/IL-17 response. Heliyon 2023; 9(9) doi: 10.1016/j.heliyon.2023.e20118
|
| 2 |
Meicheng Pan, Yawei Qian, Junjie Zhou, Yi Liu, Zhihan Xiao, Lian Gu, Nikhat Kaura. A Diagnostic Biomarker Model for Chronic Fibrosis After Liver Transplantation. International Journal of Clinical Practice 2025; 2025(1) doi: 10.1155/ijcp/6433958
|
| 3 |
Pawel E. Ferdek, Daria Krzysztofik, Kinga B. Stopa, Agnieszka A. Kusiak, Milena Paw, Dawid Wnuk, Monika A. Jakubowska. When healing turns into killing – the pathophysiology of pancreatic and hepatic fibrosis. The Journal of Physiology 2022; 600(11) doi: 10.1113/JP281135
|
| 4 |
Tongwang Yang, Zhiyun Gu, Juan Feng, Juanjuan Shan, Cheng Qian, Na Zhuang. Non-parenchymal cells: key targets for modulating chronic liver diseases. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1576739
|
| 5 |
Esam M. Aboubakr, Ahmed R. N. Ibrahim, Fares E. M. Ali, Ahmed A. E. Mourad, Adel M. Ahmad, Amal Hofni. Fasudil Ameliorates Methotrexate-Induced Hepatotoxicity by Modulation of Redox-Sensitive Signals. Pharmaceuticals 2022; 15(11) doi: 10.3390/ph15111436
|
| 6 |
FuiBoon Kai, Andrew M. Leidal, Valerie M. Weaver. Tension-induced organelle stress: an emerging target in fibrosis. Trends in Pharmacological Sciences 2025; 46(2) doi: 10.1016/j.tips.2024.12.006
|
| 7 |
Ming Yang, Ethan Vanderwert, Eric T. Kimchi, Kevin F. Staveley-O’Carroll, Guangfu Li. The Important Roles of Natural Killer Cells in Liver Fibrosis. Biomedicines 2023; 11(5) doi: 10.3390/biomedicines11051391
|
| 8 |
Yang Zhang, Yuan Wu, Wenjuan Shen, Bingyu Wang, Xingxing Yuan. Crosstalk between NK cells and hepatic stellate cells in liver fibrosis (Review). Molecular Medicine Reports 2022; 25(6) doi: 10.3892/mmr.2022.12724
|
| 9 |
Aigul Sharip, Jeannette Kunz. Mechanosignaling via Integrins: Pivotal Players in Liver Fibrosis Progression and Therapy. Cells 2025; 14(4) doi: 10.3390/cells14040266
|
| 10 |
Yue Xi, Peng-Fei Xu. Therapeutic potentials of fasudil in liver fibrosis. World Journal of Gastroenterology 2021; 27(45): 7859-7861 doi: 10.3748/wjg.v27.i45.7859
|
| 11 |
Yihan Qian, Zhi Shang, Yueqiu Gao, Hailong Wu, Xiaoni Kong. Liver Regeneration in Chronic Liver Injuries: Basic and Clinical Applications Focusing on Macrophages and Natural Killer Cells. Cellular and Molecular Gastroenterology and Hepatology 2022; 14(5) doi: 10.1016/j.jcmgh.2022.05.014
|
| 12 |
Dandan Chen, Zhikang Sun, Ying Xu, Qinglian Wang. MEF2A nuclear translocation mediated by ROCK phosphorylation promotes EZH2 expression and peritoneal fibrosis. Renal Failure 2026; 48(1) doi: 10.1080/0886022X.2026.2664318
|
| 13 |
Ting He, Yinqi Li, Zhihan Chen, Jiemei Chen. Differential functions of ROCK1 and ROCK2 in liver fibrosis and advances in targeted therapeutic strategies. Frontiers in Pharmacology 2026; 17 doi: 10.3389/fphar.2026.1929302
|
| 14 |
Rongrong Jia, Jiahuan Lu, Baining Sun, Kangnan Zhang, Na Wang, Yanqin Wen, Jiali Ma. RETRACTED: TGF - β/SMAD signaling pathway and protein molecules in the treatment of liver fibrosis: A natural lipid membrane protein of exosomes. International Journal of Biological Macromolecules 2024; 280 doi: 10.1016/j.ijbiomac.2024.135654
|
| 15 |
Rongrong Jia, Jiahuan Lu, Baining Sun, Jiali Ma, Na Wang, Yanqin Wen. Electrochemical sensors for diagnosing liver fibrosis and biomarker research: the role of NK cell-derived exosomes. Microchemical Journal 2026; 221 doi: 10.1016/j.microc.2025.116791
|
| 16 |
Hanan Abdelmawgoud Atia, Hemat A. Elariny, Marwa H. Abdallah, Amany M. Khalifa, Remon S. Estfanous, Maaly A. Abd Elmaaboud, Ahmed M. Kabel. Repositioning Perindopril for Mitigation of Methotrexate-Induced Hepatotoxicity in Rats. Pharmaceuticals 2025; 18(3) doi: 10.3390/ph18030358
|
| 17 |
Hui Luo, Ke-Cheng Lou, Ling-Yu Xie, Fei Zeng, Jun-Rong Zou. Pharmacotherapy of urethral stricture. Asian Journal of Andrology 2024; 26(1) doi: 10.4103/aja202341
|
| 18 |
Quanjuan Guo, Ailu Yang, Rongrong Zhao, Huajun Zhao, Yongliang Mu, Jian Zhang, Qiuju Han, Yuhang Su. Nimodipine ameliorates liver fibrosis via reshaping liver immune microenvironment in TAA-induced in mice. International Immunopharmacology 2024; 138 doi: 10.1016/j.intimp.2024.112586
|
| 19 |
Junwei Shao, Tiantian Ge, Cuilan Tang, Gang Wang, Lantian Pang, Zhi Chen. Synergistic anti-inflammatory effect of gut microbiota and lithocholic acid on liver fibrosis. Inflammation Research 2022; 71(10-11) doi: 10.1007/s00011-022-01629-4
|
| 20 |
Lijuan Dan, Yanwei Hao, Hongfei Song, Tianyuan Wang, Jia Li, Xiaoyan He, Yue Su. Efficacy and potential mechanisms of the main active ingredients of astragalus mongholicus in animal models of liver fibrosis: A systematic review and meta-analysis. Journal of Ethnopharmacology 2024; 319 doi: 10.1016/j.jep.2023.117198
|
| 21 |
Huihui Fan, Peilin Jia, Zhongming Zhao. Cell-Type-Specific Profibrotic Scores across Multi-Organ Systems Predict Cancer Prognosis. Cancers 2021; 13(23) doi: 10.3390/cancers13236024
|